openPR Logo
Press release

Endocrine Testing Market is expanding at a CAGR of 8.50% from 2015 - 2023

06-01-2017 02:17 PM CET | Health & Medicine

Press release from: Transparency Market Research

Endocrine Testing Market

Endocrine Testing Market

The global endocrine testing market has been broadly segmented on the basis of selected tests, diagnostic technologies, end-users, and geography. This report studies the current scenario as well as future market potential for endocrine testing globally. This report comprises an elaborate executive summary, which includes a market snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global endocrine testing market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players (%) operating in the endocrine testing market.

This 138 page report gives readers a comprehensive overview of the Endocrine Testing Market. Unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/endocrine-testing-market.html

Based on test, the global endocrine testing market has been segmented into estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market for these tests has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each type has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on diagnostic technology, the global endocrine testing market has been segmented into five major technologies such as: tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor, and clinical chemistry technologies. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Get accurate market forecast and analysis on the Endocrine Testing Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645

The end user segmentation elucidates the global endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the global endocrine testing market has been categorized into North America, Europe, Asia Pacific, and Rest of the World. The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the endocrine testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include F-Hoffmann La Roche, Ltd., Abbott Laboratories, DiaSorin, Agilent Technologies, Siemens Healthcare, Thermo Fisher Scientific, AB SCIEX LLC, Bio Rad Laboratories, Lab Corporation, bioMerieux, Sysmex Corporation, Ortho-clinical Diagnostics, Quest Diagnostics and Biomedical Diagnostics.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endocrine Testing Market is expanding at a CAGR of 8.50% from 2015 - 2023 here

News-ID: 560068 • Views:

More Releases from Transparency Market Research

Solar Micro Inverter Market to Reach USD 19.1 Bn by 2034, Driven by 15.5% CAGR Amid Rapid Residential Solar Adoption
Solar Micro Inverter Market to Reach USD 19.1 Bn by 2034, Driven by 15.5% CAGR A …
The global solar micro inverter market is entering a dynamic growth phase as renewable energy adoption accelerates worldwide. Valued at US$ 4.1 billion in 2023, the market is projected to expand at a robust CAGR of 15.5% from 2024 to 2034, reaching an estimated US$ 19.1 billion by the end of 2034. The rapid shift toward decentralized energy systems, technological innovation, and favorable government policies are positioning micro inverters as
SMT Equipment Market to Reach USD 9.1 Bn by 2031, Growing at 5.9% CAGR Amid Rising PCB Miniaturization
SMT Equipment Market to Reach USD 9.1 Bn by 2031, Growing at 5.9% CAGR Amid Risi …
The SMT Equipment Market is witnessing steady expansion driven by the rapid evolution of consumer electronics, automotive electronics, telecommunications infrastructure, industrial automation, and advanced computing systems. Surface Mount Technology (SMT) equipment is used in the manufacturing of printed circuit boards (PCBs) by mounting electronic components directly onto the surface of the boards. This technology has become the backbone of modern electronics production due to its efficiency, miniaturization capability, and cost-effectiveness. Explore
Bio-Based Flavors and Fragrances Market to Reach US$ 4.56 Billion by 2031, Driven by Natural Ingredients and Sustainable Cosmetic & Food Applications | Latest Report TMR
Bio-Based Flavors and Fragrances Market to Reach US$ 4.56 Billion by 2031, Drive …
The global bio-based flavors and fragrances market was valued at US$ 1,945.0 Million in 2021 and is projected to reach US$ 4,555.5 Million by 2031, growing at a CAGR of 8.3% from 2022 to 2031. This robust growth is driven by increasing consumer preference for natural and health-oriented ingredients, rising adoption of eco-friendly cosmetic and food products, and expanding applications in the pharmaceutical industry. Access key findings and insights from our
Breast Tissue Markers Market to Surpass USD 5.8 Billion by 2031, Driven by Rising Breast Cancer Incidence and Growth in Minimally Invasive Biopsy Procedures
Breast Tissue Markers Market to Surpass USD 5.8 Billion by 2031, Driven by Risin …
The global breast tissue markers market was valued at US$ 2.5 Bn in 2021 and is projected to expand at a CAGR of 8.3% from 2022 to 2031, reaching more than US$ 5.8 Bn by the end of 2031. The market is witnessing steady growth due to the rising incidence of breast cancer, increasing adoption of minimally invasive biopsy procedures, and advancements in diagnostic imaging technologies. Get Your Sample Report -

All 5 Releases


More Releases for Endocrine

Endocrine Testing: A Leading Driver Behind Impact of Diabetes Prevalence on Endo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Endocrine Testing Industry Market Size Be by 2025? In recent times, there has been a significant expansion in the size of the endocrine testing market. The market is projected to expand from $2.55 billion in 2024 to $2.8 billion in 2025, reflecting a compound annual growth
Evolving Market Trends In The Endocrine Peptide Test Industry: Advancements in I …
The Endocrine Peptide Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Endocrine Peptide Test Market Size During the Forecast Period? The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to
Key Influencer in the Endocrine Testing Market 2025: Impact of Diabetes Prevalen …
What industry-specific factors are fueling the growth of the endocrine testing market? The growing prevalence of diabetes is also expected to drive the endocrine testing market. Similar to the peptide tests, endocrine testing is crucial for diagnosing, monitoring, and managing diabetes. As the disease becomes more prevalent, especially among younger populations, the demand for these diagnostic tests increases. According to NHS data from June 2024, diabetes diagnoses in individuals under 40
Key Influencer in the Endocrine Peptide Test Market 2025: Impact of Diabetes Pre …
What Is the Forecasted Market Size and Growth Rate for the Endocrine Peptide Test Market? The market size for endocrine peptide tests has significantly expanded in the recent past. The growth is slated to rise from $9.11 billion in 2024 to a significant $9.97 billion in 2025. This translates to a compound annual growth rate (CAGR) of 9.5%. The expansion during the historic phase is linked to factors like increased government
Impact of Diabetes Prevalence on Endocrine Testing Market Growth Driver: Leading …
"What Are the Projected Growth and Market Size Trends for the Endocrine Testing Market? In the past few years, the endocrine testing market has seen a significant expansion. The market, which is worth $2.55 billion in 2024, is projected to reach $2.8 billion in the following year, growing at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the historic period include the discovery of hormones
Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is